Compliance with cardiovascular disease prevention strategies: a review of the research.
The efficacy of cardiovascular risk-reduction programs has been established. However, the extent to which risk-reduction interventions are effective may depend on adherence. Non-compliance, or non-adherence, may occur with any of the recommended or prescribed regimens and may vary across the treatment course. Compliance problems, whether occurring early or late in the treatment course, are clinically significant, as adherence is one mediator of the clinical outcome. This article, which is based on a review of the empirical literature of the past 20 years, addresses compliance across four regimens of cardiovascular risk reduction: pharmacological therapy, exercise, nutrition, and smoking cessation. The criteria for inclusion of a study in this review were: (a) focus on cardiovascular disease risk reduction; (b) report of a quantitative measure of compliance behavior; and (c) use of a randomized controlled design. Forty-six studies meeting these criteria were identified. A variety of self-report, objective, and electronic measurement methods were used across these studies. The interventions employed diverse combinations of cognitive, educational, and behavioral strategies to improve compliance in an array of settings. The strategies demonstrated to be successful in improving compliance included behavioral skill training, self-monitoring, telephone/mail contact, self-efficacy enhancement, and external cognitive aids. A series of tables summarize the intervention strategies, compliance measures, and findings, as well as the interventions demonstrated to be successful. This review reflects the progress made over two decades in compliance measurement and research and, further, advances made in the application of behavioral strategies to the promotion of cardiovascular risk reduction.
Burke
L E
LE
University of Pittsburgh, School of Medicine, Department of Psychiatry, PA 15213, USA.
Dunbar-Jacob
J M
JM
Hill
M N
MN
D001521:Behavior Therapy; D002317:Cardiovascular Agents / Q000008:administration & dosage; D002318:Cardiovascular Diseases / Q000517:prevention & control* / Q000523:psychology; D018752:Diet, Fat-Restricted / Q000523:psychology; D015444:Exercise / Q000523:psychology; D006801:Humans; D010349:Patient Compliance / Q000523:psychology*; D012307:Risk Factors; D016540:Smoking Cessation / Q000523:psychology; D016896:Treatment Outcome
D002317:Cardiovascular Agents